
Capecad 500mg Tablet
Marketer
Cadila Pharmaceuticals Ltd
Salt Composition
Capecitabine (500mg)
Overview Capecad 500mg Tablet
Xeloda 500mg tablets are indicated for treating breast, colorectal, and rectal cancers. Other uses may be prescribed by a physician. It's administered alone or in combination with other drugs as part of chemotherapy regimens. Consume Xeloda 500mg tablets with food, within 30 minutes post-meal. Dosage and frequency are determined by your doctor, based on your condition, and may vary. Strictly adhere to the prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent immediately; continue treatment unless otherwise directed by your doctor. Common side effects include nausea, vomiting, weakness, abdominal discomfort, and diarrhea. This medication can lower blood cell counts (especially white blood cells), increasing infection risk. Regular blood tests monitoring blood cell levels, hepatic and renal function, and uric acid are essential. Inform your doctor of any pre-existing liver or kidney conditions, or concurrent use of anti-infectives before commencing treatment. Drug interactions are possible; disclose all medications to your doctor. This medication is contraindicated during pregnancy and lactation. Reliable contraception for both partners is crucial throughout treatment to prevent conception.
Primary Ingredients of Capecad 500mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Capecad 500mg Tablet
Carcinoma of the breast and colorectal cancer
Major Benefits of Capecad 500mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the 500mg Capecad tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.
Common Side effects of Capecad 500mg Tablet:
- Vomiting
- Weakness
- Nausea
- Abdominal pain
- Diarrhea
- Blisters on fingers/feet
How to use Capecad 500mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the 500mg Capecad tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with food.
How Capecad 500mg Tablet works:
Capecitabine 500mg tablets are a cancer treatment. Metabolized within the body into 5-fluorouracil, it disrupts the production of RNA and DNA in cancerous cells, inhibiting their proliferation. This ultimately leads to a reduction in cancer cell growth and their eventual destruction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Capecad 500mg Tablet may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Capecitabine 500mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated, except in potentially life-threatening circumstances where a physician deems the benefits outweigh the risks. Always seek medical advice.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Capecitabine 500mg tablets. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Taking a 500mg Capecad tablet may cause drowsiness, blurred vision, dizziness, and reduced awareness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should use Capecad 500mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Capecad 500mg tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with liver impairment should use Capecad 500mg tablets cautiously, potentially requiring dosage modification under medical supervision. The use of Capecad 500mg tablets is contraindicated in individuals with severe renal dysfunction.
What if you forget to take Capecad 500mg Tablet :
NA
Facts to Know About Capecad 500mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Modified Deoxycytidine |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Metabolic inhibitors |
